机译:大肠中心无法切除的肝转移患者行孤立性肝灌注治疗的结果相关因素分析
Surgical Metabolism Section Surgery Branch Center for Cancer Research National Cancer Institute Bethesda MD USA;
Surgical Metabolism Section Surgery Branch Center for Cancer Research National Cancer Institute Bethesda MD USA;
Surgical Metabolism Section Surgery Branch Center for Cancer Research National Cancer Institute Bethesda MD USA;
Surgical Metabolism Section Surgery Branch Center for Cancer Research National Cancer Institute Bethesda MD USA;
Surgical Metabolism Section Surgery Branch Center for Cancer Research National Cancer Institute Bethesda MD USA;
Biostatistics and Data Management Section Center for Cancer Research National Cancer Institute Bethesda MD USA;
Surgical Metabolism Section Surgery Branch Center for Cancer Research National Cancer Institute Bethesda MD USA;
Surgical Metabolism Section Surgery Branch Center for Cancer Research National Cancer Institute Bethesda MD USA;
机译:结直肠中心无法切除的肝转移患者接受孤立肝灌注的患者结局相关因素分析。
机译:使用5-FU和奥沙利铂治疗无法切除的大肠癌肝转移患者的分离性肝灌注(IHP)I期试验
机译:大肠肝转移的单纯肝美法仑灌注:154例患者的结局和预后因素。
机译:超过750个基因的高深度测序支持肝脏有限转移性结直肠癌大多数患者的原发性肿瘤和转移的线性进展
机译:大肠癌肝转移患者影像和手术的成本效益。
机译:使用5-FU和奥沙利铂治疗无法切除的大肠癌肝转移患者的孤立性肝灌注(IHP)I期试验
机译:使用5-FU和OHP)的分离肝灌注(IHP)在结肠直肠癌中不可切除的分离肝转移患者中的分离肝灌注(IHP)的一期。